Lamotrigine
Brand names,
Lamotrigine
Analogs
Lamotrigine
Brand Names Mixture
Lamotrigine
Chemical_Formula
C9H7Cl2N5
Lamotrigine
RX_link
http://www.rxlist.com/cgi/generic/lamotrigine.htm
Lamotrigine
fda sheet
Lamotrigine
msds (material safety sheet)
Lamotrigine
Synthesis Reference
M. G. Baxter et al., Eur. pat. Appl. 21,121 (1981 to Wellcome Foundation); D. A. Sawyer et al., U.S. pat. 4,602,017 (1986)
Lamotrigine
Molecular Weight
256.091 g/mol
Lamotrigine
Melting Point
216-218 oC (uncorr)
Lamotrigine
H2O Solubility
No information avaliable
Lamotrigine
State
Solid
Lamotrigine
LogP
1.497
Lamotrigine
Dosage Forms
Tablet; Chewable
Lamotrigine
Indication
For the adjunctive treatment of partial seizures in epilepsy and generalized seizures of Lennox-Gastaut syndrome; For the maintenance treatment of Bipolar I Disorder
Lamotrigine
Pharmacology
Lamotrigine, an antiepileptic drug (AED) of the phenyltriazine class, is chemically unrelated to existing antiepileptic drugs. Lamotrigine is also used in the treatment of depression and bipolar disorder. Lamotrigine is thought to exert its anticonvulsant effect by stabilizing presynaptic neuronal membranes. Lamotrigine inhibits sodium currents by selectively binding to the inactivated state of the sodium channel and subsequently suppresses the release of the excilatory amino acid, glutamate.
Lamotrigine
Absorption
98%
Lamotrigine
side effects and Toxicity
LD50=250 (mg/kg) (in rat, mice); LD50>640 orally (mg/kg) (in rat, mice) (Sawyer); Decreased level of consciousness, coma, delayed heartbeat, increased seizures, lack of coordination, rolling eyeballs
Lamotrigine
Patient Information
Lamotrigine
Organisms Affected
Humans and other mammals